Neutrophils: Tissue and Circulating Signatures of Pediatric Non-alcoholic Fatty Liver Disease

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2024 Jan 19

PMID 38239291

Authors

Maria Oana Sasaran

Carmen Muntean

Ancuta Lupu

Vasile Valeriu Lupu

Affiliations

Soon will be listed here.

Abstract

The recent rise in non-alcoholic fatty liver disease (NAFLD) among children and adolescents led to a thorough investigation of the peculiarities of the cellular infiltrate which characterize the disease at young ages. This review aims to highlight the key involvement of neutrophils in the pathogenesis of pediatric NAFLD and the potential biomarker role of neutrophil-to-lymphocyte ratio (NLR) in the same pediatric disorder. Neutrophils, which are first responders to inflammation, constitute an abundant component of an infiltrate which is particularly disposed within the portal area of children with NAFLD. The involvement of neutrophils in triggering liver fibrosis has been related amongst others to reactive oxygen species (ROS) production, to the stimulation of hepatic stellate cells, and to their synthesis of neutrophil elastase. As immune imbalance characterizes NAFLD, potentially emerging non-invasive biomarkers such as NLR have been proposed for the detection and prognosis of NAFLD. In adults, several studies asserted the role of NLR in the prediction of advancing liver fibrosis and mortality in subjects with NAFLD. In children, data is scarce with contradicting findings, as some studies failed to identify significant shifting in NLR values in children with NAFLD when compared with obese controls without liver impairment. However, NLR seems to significantly increase in children with obesity and different degrees of NAFLD when compared to healthy counterparts and their changes seem to be reversible with weight loss. Still, paucity of pediatric studies calls for future research addressing the role of NLR in predicting NAFLD development and progression in children with obesity.

References

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Pulli B, Ali M, Iwamoto Y, Zeller M, Schob S, Linnoila J . Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis. Antioxid Redox Signal. 2015; 23(16):1255-69. PMC: 4677570. DOI: 10.1089/ars.2014.6108. View

Paquissi F . Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Front Immunol. 2016; 7:490. PMC: 5104753. DOI: 10.3389/fimmu.2016.00490. View

Berardis S, Sokal E . Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr. 2013; 173(2):131-9. PMC: 3929043. DOI: 10.1007/s00431-013-2157-6. View

Papayannopoulos V . Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2017; 18(2):134-147. DOI: 10.1038/nri.2017.105. View

Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi T, Yerian L . Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2011; 32(2):297-302. DOI: 10.1111/j.1478-3231.2011.02639.x. View

Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu Y, McCullough A . Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6):1413-9. DOI: 10.1016/s0016-5085(99)70506-8. View

Cucoranu D, Pop M, Niculescu R, Kosovski I, Toganel R, Licu R . The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio. Cureus. 2023; 15(6):e41197. PMC: 10387286. DOI: 10.7759/cureus.41197. View

Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elmahdy Y, Elhelaly R . A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Eur J Gastroenterol Hepatol. 2015; 28(1):e1-9. DOI: 10.1097/MEG.0000000000000486. View

10.

Marginean C, Melit L, Sasaran M . Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. Biomedicines. 2021; 9(12). PMC: 8698557. DOI: 10.3390/biomedicines9121866. View

11.

Nathan C . Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006; 6(3):173-82. DOI: 10.1038/nri1785. View

12.

Kim H, Chung G, Park I, Choi J, Hwang S, Lee J . Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease. Tohoku J Exp Med. 2011; 223(3):227-33. DOI: 10.1620/tjem.223.227. View

13.

Marra A, Bondesan A, Caroli D, Grugni G, Sartorio A . The neutrophil to lymphocyte ratio (NLR) positively correlates with the presence and severity of metabolic syndrome in obese adults, but not in obese children/adolescents. BMC Endocr Disord. 2023; 23(1):121. PMC: 10224327. DOI: 10.1186/s12902-023-01369-4. View

14.

Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G . A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010; 53(2):372-84. DOI: 10.1016/j.jhep.2010.04.008. View

15.

Ou R, Liu J, Lv M, Wang J, Wang J, Zhu L . Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice. Endocrine. 2017; 57(1):72-82. DOI: 10.1007/s12020-017-1323-4. View

16.

Mirea A, Toonen E, van den Munckhof I, Munsterman I, Tjwa E, Jaeger M . Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. Mol Med. 2019; 25(1):16. PMC: 6498541. DOI: 10.1186/s10020-019-0084-3. View

17.

Hubscher S . Histological assessment of non-alcoholic fatty liver disease. Histopathology. 2006; 49(5):450-65. DOI: 10.1111/j.1365-2559.2006.02416.x. View

18.

Rensen S, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A . Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol. 2009; 175(4):1473-82. PMC: 2751544. DOI: 10.2353/ajpath.2009.080999. View

19.

Jimenez Calvente C, Tameda M, Johnson C, Del Pilar H, Lin Y, Adronikou N . Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019; 129(10):4091-4109. PMC: 6763256. DOI: 10.1172/JCI122258. View

20.

Viglino D, Jullian-Desayes I, Minoves M, Aron-Wisnewsky J, Leroy V, Zarski J . Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J. 2017; 49(6). DOI: 10.1183/13993003.01923-2016. View